Gilead
More News
-
WHO advises against remdesivir drug for all Covid-19 patients
Manufacturer Gilead questions Solidarity Trial’s results, says it was disappointed at the new WHO guideline
-
Gilead's Covid-19 antiviral remdesivir gets conditional EU clearance
Remdesivir is in high demand after the medicine helped to shorten hospital recovery times in a clinical trial
-
Gilead trades that made millions on Covid-19 drug news raise eyebrows
Gilead’s shares jumped nearly 10% following a media report detailing encouraging partial data from trials
-
US emergency approval broadens use of Gilead's Covid-19 drug remdesivir
Gilead had said the drug helped improve outcomes for patients with coronavirus
-
Gilead says remdesivir shows improvement in Covid-19 patients when used early
In Gilead's study, 62% of patients treated early were discharged from the hospital




